🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: DISKUS inhaler

Found 109 matching trials

GSK159802 In Healthy Male Subjects And Asthmatics

PHASE1

GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...

Status

Completed

Location

GSK Investigational Site

Start Date

2005-08-24

Trial ID

NCT00364273

Treatments Being Tested

GSK159802 Placebo Salmeterol

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients

PHASE3

The purpose of this study is to demonstrate the pharmacodynamic bioequivale...

Status

Completed

Location

Combined Research Orlando

Start Date

2018-10-17

Trial ID

NCT03394989

Treatments Being Tested

Fluticasone propionate/salmeterol 100/50 µg Placebo Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

PHASE2

This is a randomized, placebo-controlled, 2-period crossover, escalating re...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-02-09

Trial ID

NCT02991859

Treatments Being Tested

Fluticasone furoate (FF) Dry Powder Inhaler Fluticasone propionate (FP) Dry Powder Inhaler Budesonide (BUD) Turbuhaler Placebo (ELLIPTA or DISKUS)

A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers

PHASE1

Bioequivalence study between two inhaler products of fixed dose combination...

Status

Completed

Location

BECRO Clinical Facility

Start Date

2018-11-20

Trial ID

NCT03751202

Treatments Being Tested

Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg ADVAIR DISKUS

Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

This study compared the 14-day bronchodilator efficacy of indacaterol with ...

Status

Completed

Location

Novartis Investigator Site

Start Date

2010-03

Trial ID

NCT01089127

Treatments Being Tested

Indacaterol Salmeterol 50 μg Placebo to indacaterol Placebo to salmeterol

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

PHASE3

A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-10-13

Trial ID

NCT02924688

Treatments Being Tested

FF/UMEC/VI (100/31.25/25) mcg FF/UMEC/VI (100/62.5/25) mcg FF/UMEC/VI (200/31.25/25) mcg FF/UMEC/VI (200/62.5/25) mcg FF/VI (100/25) mcg FF/VI (200/25) mcg Fluticasone/salmeterol (FSC)Albuterol/salbutamol ELLIPTA DPI DISKUS DPI METERED-DOSE INHALER (MDI)

Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD

This is a randomized, multi-center, active-controlled, repeated measures de...

Status

Completed

Location

3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa

Start Date

2016-04

Trial ID

NCT02757209

Treatments Being Tested

Spiromax (budesonide/formoterol)Turbohaler (budesonide/formoterol)Diskus(50mcg salmeterol &250/500 mcg fluticasone propionate)

Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

This randomized, cross over study aims to find out the benefits of deliveri...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-09-20

Trial ID

NCT03227445

Treatments Being Tested

ELLIPTA placebo DPI DISKUS placebo DPI HandiHaler placebo DPI Inhaler preference questionnaires

Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients

PHASE4

The primary objective of this study is to evaluate the effect of Beclometha...

Status

Terminated

Location

National Jewish Medical and Research Center

Start Date

2004-01-31

Trial ID

NCT00071552

Treatments Being Tested

Qvar Flovent Diskus

Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)

PHASE3

Asthma is a common, serious illness among children in the United States. Wh...

Status

Completed

Location

University of Arizona College of Medicine

Start Date

2007-03

Trial ID

NCT00395304

Treatments Being Tested

fluticasone propionate + montelukast fluticasone propionate fluticasone propionate + salmeterol

Previous Next